This continues the decline that began yesterday on the same Epstein inquiry news, with BK underperforming its sector by over 2 percentage points despite positive analyst actions (Goldman Sachs raised PT to $143, Wells Fargo to $122). The reputational and potential regulatory risk from the Senate inquiry appears to be weighing on shares more than the solid fundamentals would suggest. For context, multiple analysts maintained Buy ratings following strong Q4 results with record revenue and raised margin targets.
This is a permanent link to this specific analysis (ID: 2539)
Back to Dashboard